USPTO serial 79455685
TORQUR
Reviewed by CopyMark Law Group
Status 640Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- GUTIERREZ, GREGORY T
- Law office
- TMO LAW OFFICE 120
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with TORQUR?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Active chemical ingredients used in the manufacture of cancer medicines and vaccines, medicines for treatment and prevention of dermatological or neurodegenerative diseases or disorders, as well as vaccines | ACTIVE | — |
| 005 | Pharmaceutical products, substances and preparations, in particular for treatment and prevention of cancer, dermatological or neurodegenerative diseases or disorders; medicinal preparations | ACTIVE | — |
| 042 | Scientific services; scientific advice and information services; preparation of scientific reports; medical research; scientific research, in particular for prevention and treatment of cancer, dermatological or neurodegenerative diseases or disorders | ACTIVE | — |
| 044 | Medical services, in particular for treatment and prevention of cancer, dermatological or neurodegenerative diseases or disorders; medical advice and information services; medical analysis services, in particular for diagnosis, treatment and prevention of cancer, dermatological or neurodegenerative diseases or disorders; medical analysis services provided by medical laboratories for diagnostic and therapeutic purposes; RNA or DNA analysis for prognosis and diagnosis of cancer, dermatological or neurodegenerative diseases or disorders; provision of information in the field of prevention, screening, diagnosis and treatment of cancers, dermatological or neurodegenerative diseases or disorders | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 15, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Aug 19, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 18, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 18, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 10, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 10, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 6, 2026 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |